Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains

Journal of Infectious Diseases

Volumn 202, Issue 12, 2010, Pages 1866-1876

  Li, Min ^a   Cheung, Gordon Y C ^c   Hu, Jinhui ^a   Wang, Decheng ^b   Joo, Hwang Soo ^b   DeLeo, Frank R ^c   Otto, Michael ^c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; BACTERIAL TOXIN; PANTON VALENTINE LEUKOCIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLYSIS; FEMALE; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SKIN ABSCESS; SKIN INFECTION;

ANIMALS; BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; DISEASE MODELS, ANIMAL; EXOTOXINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HEMOLYSIN PROTEINS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPHILS; RABBITS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

EID: 78650374700     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/657419     Document Type: Article

References (44)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
2. Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003; 111:1265-1273.
3. Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629-641.
4. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375: 1557-1568.
5. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186: 1344-1347. (Pubitemid 35193015)
6. Diep BA, Stone GG, Basuino L, et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillinresistant Staphylococcus aureus. J Infect Dis 2008; 197:1523-1530.
7. Chambers HF. Community-associated MRSA-resistance and virulence converge. N Engl J Med 2005; 352:1485-1487.
8. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-674.
9. Kennedy AD, Otto M, Braughton KR, et al. Epidemic communityassociated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 2008; 105: 1327-1332.
10. Diep BA, Otto M. The role of virulence determinants in communityassociated MRSA pathogenesis. Trends Microbiol 2008; 16:361-369.
11. Vandenesch F, Naimi T, Enright MC, et al. Community-acquiredmethicillin- resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-984.
12. Hongo I, Baba T, Oishi K, Morimoto Y, Ito T, Hiramatsu K. Phenolsoluble modulin alpha 3 enhances the human neutrophil lysismediated by Panton-Valentine leukocidin. J Infect Dis 2009; 200:715-723.
13. Loffler B, Hussain M, Grundmeier M, et al. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010; 6:e1000715.
14. Graves SF, Kobayashi SD, Braughton KR, et al. Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants. Microbes Infect 2010; 12:446-456.
15. Koh SS, Opel ML, Wei JP, et al. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalinfixed and paraffin-embedded tissue. Mod Pathol 2009; 22:538-546.
16. Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci U S A 2002; 99:6901-6906.
17. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine Leukocidin the Major Virulence Determinant in Community-Associated methicillin-resistant Staphylococcus aureus Disease? J Infect Dis 2006; 194: 1761-1770.
18. Wu M, Hancock RE. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 1999; 274:29-35.
19. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510-1514.
20. Limbago B, Fosheim GE, Schoonover V, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009; 47:1344-1351.
21. Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 2009; 106:5883-5888.
22. DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 2009; 23:17-34.
23. Voyich JM, Braughton KR, Sturdevant DE, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-3919.
24. Palazzolo-Ballance AM, Reniere ML, Braughton KR, et al. Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol 2008; 180:500-509.
25. BubeckWardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405-1406.
26. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A 2010; 107: 5587-5592.
27. Queck SY, Jameson-Lee M, Villaruz AE, et al. RNAIII-Independent Target Gene Control by the agr Quorum-Sensing System: Insight into the Evolution of Virulence Regulation in Staphylococcus aureus. Mol Cell 2008; 32:150-158.
28. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol Gen Genet 1986; 202:58-61.
29. Panton PN, Valentine FCO. Staphylococcal toxin. Lancet 1932; 1: 506-508.
30. Badiou C, Dumitrescu O, George N, et al. Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic tests. J Clin Microbiol 2010; 48:1384-1390.
31. Somerville GA, Cockayne A, Durr M, Peschel A, Otto M, Musser JM. Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol 2003; 185: 6686-6694.
32. Otter JA, French GL. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010; 10:227-239.
33. Brown EL, Dumitrescu O, Thomas D, et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 2009; 15(2):156-164.
34. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008; 198:1166-1170.
35. Tseng CW, Kyme P, Low J, et al. Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One 2009; 4:e6387.
36. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-1132.
37. Bae IG, Tonthat GT, Stryjewski ME, et al. Presence of genes encoding the Panton-Valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 2009; 47(12):3952-3957.
38. Varshney AK, Martinez LR, Hamilton SM, et al. Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant andmethicillin- susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model. J Infect Dis 2010; 201:92-96.
39. Villaruz AE, Wardenburg JB, Khan BA, et al. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J Infect Dis 2009; 200:724-734.
40. Valeva A, Walev I, Pinkernell M, et al. Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A 1997; 94:11607-11611.
41. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006; 193:1495-1503.
42. Centers for Disease Control and Prevention (CDC). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 1999; 282: 1123-1125.
43. Witte W, Strommenger B, Cuny C, Heuck D, Nuebel U. Methicillinresistant Staphylococcus aureus containing the Panton-Valentine leukocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 2007; 60:1258-1263.
44. Lee SS, Kim YJ, Chung DR, Jung KS, Kim JS. Invasive infection caused by community-associated methicillin- resistant Staphylococcus aureus strain not carrying Panton-Valentine leukocidin in South Korea. J Clin Microbiol 2010; 48(1):311-313.